These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8630011)

  • 1. Monoclonal antibodies to the EGF receptor act as betacellulin antagonists.
    Modjtahedi H; Dean C
    Biochem Biophys Res Commun; 1996 Apr; 221(3):625-30. PubMed ID: 8630011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
    Modjtahedi H; Komurasaki T; Toyoda H; Dean C
    Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
    Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
    Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
    Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
    Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
    Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines.
    Ruck A; Paulie S
    Anticancer Res; 1998; 18(3A):1447-52. PubMed ID: 9673354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
    Riese DJ; Bermingham Y; van Raaij TM; Buckley S; Plowman GD; Stern DF
    Oncogene; 1996 Jan; 12(2):345-53. PubMed ID: 8570211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity.
    Mixan B; Cohen BD; Bacus SS; Fell HP; Siegall CB
    Oncogene; 1998 Mar; 16(9):1209-15. PubMed ID: 9528863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.
    Modjtahedi H; Moscatello DK; Box G; Green M; Shotton C; Lamb DJ; Reynolds LJ; Wong AJ; Dean C; Thomas H; Eccles S
    Int J Cancer; 2003 Jun; 105(2):273-80. PubMed ID: 12673691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
    Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
    Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of HB-EGF to tumour cells is blocked by mAbs which act as EGF and TGF alpha antagonists.
    Modjtahedi H; Dean C
    Biochem Biophys Res Commun; 1995 Feb; 207(1):389-97. PubMed ID: 7857293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of epidermal growth factor receptor during corneal epithelial migration.
    Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the betacellulin receptor in pancreatic AR42J cells.
    Ishiyama N; Kanzaki M; Seno M; Yamada H; Kobayashi I; Kojima I
    Diabetologia; 1998 Jun; 41(6):623-8. PubMed ID: 9662041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB; Haugland HK; Bjerkvig R
    Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.